145 related articles for article (PubMed ID: 28267914)
1. Activity Based Protein Profiling Leads to Identification of Novel Protein Targets for Nerve Agent VX.
Carmany D; Walz AJ; Hsu FL; Benton B; Burnett D; Gibbons J; Noort D; Glaros T; Sekowski JW
Chem Res Toxicol; 2017 Apr; 30(4):1076-1084. PubMed ID: 28267914
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous Time-concentration Analysis of Soman and VX Adducts to Butyrylcholinesterase and Albumin by LC-MS-MS.
Lee JY; Kim C; Lee YH
J Anal Toxicol; 2018 Jun; 42(5):293-299. PubMed ID: 29618078
[TBL] [Abstract][Full Text] [Related]
3. Modification of human serum albumin by the nerve agent VX: microbore liquid chromatography/electrospray ionization high-resolution time-of-flight tandem mass spectrometry method for detection of phosphonylated tyrosine and novel cysteine containing disulfide adducts.
Kranawetvogl A; Worek F; Thiermann H; John H
Rapid Commun Mass Spectrom; 2016 Oct; 30(19):2191-200. PubMed ID: 27490696
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and reaction networks of H2O2 vapor with NH3 gas for decontamination of the toxic warfare nerve agent, VX on a solid surface.
Gon Ryu S; Wan Lee H
J Environ Sci Health A Tox Hazard Subst Environ Eng; 2015; 50(14):1417-27. PubMed ID: 26327407
[TBL] [Abstract][Full Text] [Related]
5. [The VR, the Russian version of the nerve agent VX].
Cuquel AC; Dorandeu F; Ceppa F; Renard C; Burnat P
Ann Pharm Fr; 2015 May; 73(3):180-9. PubMed ID: 25592653
[TBL] [Abstract][Full Text] [Related]
6. Determining a threshold sub-acute dose leading to minimal physiological alterations following prolonged exposure to the nerve agent VX in rats.
Bloch-Shilderman E; Rabinovitz I; Egoz I; Yacov G; Allon N; Nili U
Arch Toxicol; 2018 Feb; 92(2):873-892. PubMed ID: 29127449
[TBL] [Abstract][Full Text] [Related]
7. Bioanalytical verification of V-type nerve agent exposure: simultaneous detection of phosphonylated tyrosines and cysteine-containing disulfide-adducts derived from human albumin.
Kranawetvogl A; Küppers J; Siegert M; Gütschow M; Worek F; Thiermann H; Elsinghorst PW; John H
Anal Bioanal Chem; 2018 Feb; 410(5):1463-1474. PubMed ID: 29322229
[TBL] [Abstract][Full Text] [Related]
8. In vivo microdialysis and electroencephalographic activity in freely moving guinea pigs exposed to organophosphorus nerve agents sarin and VX: analysis of acetylcholine and glutamate.
O'Donnell JC; McDonough JH; Shih TM
Arch Toxicol; 2011 Dec; 85(12):1607-16. PubMed ID: 21695469
[TBL] [Abstract][Full Text] [Related]
9. RSDL decontamination of human skin contaminated with the nerve agent VX.
Thors L; Lindberg S; Johansson S; Koch B; Koch M; Hägglund L; Bucht A
Toxicol Lett; 2017 Mar; 269():47-54. PubMed ID: 28179194
[TBL] [Abstract][Full Text] [Related]
10. Optimization of the Ocular Treatment Following Organophosphate Nerve Agent Insult.
Egoz I; Nili U; Grauer E; Gore A
Toxicol Sci; 2017 Sep; 159(1):50-63. PubMed ID: 28903494
[TBL] [Abstract][Full Text] [Related]
11. Tracing and attribution of V-type nerve agents in human exposure by strategy of assessing the phosphonylated and disulfide adducts on ceruloplasmin.
Fu F; Chen J; Zhao P; Lu X; Gao R; Chen D; Liu H; Wang H; Pei C
Toxicology; 2020 Jan; 430():152346. PubMed ID: 31857189
[TBL] [Abstract][Full Text] [Related]
12. Phosphoproteomic analysis reveals compensatory effects in the piriform cortex of VX nerve agent exposed rats.
Nirujogi RS; Wright JD; Manda SS; Zhong J; Na CH; Meyerhoff J; Benton B; Jabbour R; Willis K; Kim MS; Pandey A; Sekowski JW
Proteomics; 2015 Jan; 15(2-3):487-99. PubMed ID: 25403869
[TBL] [Abstract][Full Text] [Related]
13. Post-exposure treatment of VX poisoned guinea pigs with the engineered phosphotriesterase mutant C23: a proof-of-concept study.
Worek F; Seeger T; Reiter G; Goldsmith M; Ashani Y; Leader H; Sussman JL; Aggarwal N; Thiermann H; Tawfik DS
Toxicol Lett; 2014 Nov; 231(1):45-54. PubMed ID: 25195526
[TBL] [Abstract][Full Text] [Related]
14. Single treatment of VX poisoned guinea pigs with the phosphotriesterase mutant C23AL: Intraosseous versus intravenous injection.
Wille T; Neumaier K; Koller M; Ehinger C; Aggarwal N; Ashani Y; Goldsmith M; Sussman JL; Tawfik DS; Thiermann H; Worek F
Toxicol Lett; 2016 Sep; 258():198-206. PubMed ID: 27397758
[TBL] [Abstract][Full Text] [Related]
15. Identification of V-type nerve agents in vapor samples using a field-portable capillary gas chromatography/membrane-interfaced electron ionization quadrupole mass spectrometry instrument with Tri-Bed concentrator and fluoridating conversion tube.
Ohrui Y; Nagoya T; Kurimata N; Sodeyama M; Seto Y
J Mass Spectrom; 2017 Jul; 52(7):472-479. PubMed ID: 28544043
[TBL] [Abstract][Full Text] [Related]
16. Acute and long-term effects of VX in rat brain cell aggregate culture.
Sawyer TW; Wang Y; Villanueva M; Song Y; Hennes G
Toxicol In Vitro; 2022 Feb; 78():105256. PubMed ID: 34653647
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous quantification of soman and VX adducts to butyrylcholinesterase, their aged methylphosphonic acid adduct and butyrylcholinesterase in plasma using an off-column procainamide-gel separation method combined with UHPLC-MS/MS.
Liu CC; Huang GL; Xi HL; Liu SL; Liu JQ; Yu HL; Zhou SK; Liang LH; Yuan L
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Nov; 1036-1037():57-65. PubMed ID: 27718463
[TBL] [Abstract][Full Text] [Related]
18. Liquid chromatography tandem mass spectrometry applied to quantitation of the organophosphorus nerve agent VX in microdialysates from blood probes.
Stubbs SJ; Read RW
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(17-18):1253-6. PubMed ID: 20034857
[TBL] [Abstract][Full Text] [Related]
19. Novel bifunctional hybrid small molecule scavengers for mitigating nerve agents toxicity.
Amitai G; Gez R; Raveh L; Bar-Ner N; Grauer E; Chapman S
Chem Biol Interact; 2016 Nov; 259(Pt B):187-204. PubMed ID: 27129421
[TBL] [Abstract][Full Text] [Related]
20. Rapid quantification of two chemical nerve agent metabolites in serum.
Kammer M; Kussrow A; Carter MD; Isenberg SL; Johnson RC; Batchelor RH; Jackson GW; Bornhop DJ
Biosens Bioelectron; 2019 Apr; 131():119-127. PubMed ID: 30826646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
